Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Grönefeld, G.C.
Right arrow Articles by Hohnloser, S.H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Grönefeld, G.C.
Right arrow Articles by Hohnloser, S.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Quality of life in atrial fibrillation: an increasingly important issue

G.C. Grönefeld and S.H. Hohnloser1

Department of Medicine, Division of Cardiology, J. W. Goethe University, Frankfurt am Main, Germany

1 Stefan H. Hohnloser, MD, FESC, FACC, Department of Medicine, Division of Cardiology, J. W. Goethe-University, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.

Abstract

Atrial fibrillation (AF) is the most commonly sustained arrhythmia and it is the most heterogeneous arrhythmia with regard to the individual spectrum of resulting symptoms. Assessment of quality of life has received increasing attention as an outcome measure of the subjective sequelae of the disease. At present, conclusive data concerning the prognostic benefits of any therapeutic intervention are lacking, with the exception of the proven need for antithrombotic treatment. Therefore, assessment of any benefit from treatment in the management of patients with AF depends on documentation of symptomatic improvement. Exercise tolerance, duration of sinus rhythm after cardioversion and number of relapses with paroxysmal AF, for example, have been used as study end-points for evaluating different therapeutic modalities. Although these factors — as assessed in controlled studies — reflect some effect of treatment, these surrogate end-points were often not accompanied by appropriate measurements of the subjective improvement in patient's symptoms. Health-related quality of life is a summarized outcome assessment that is designed to reflect the subjective impairment in general well being caused by individual aspects of pain, and psychological, emotional and physical disturbances. In addition, measures of quality of life take into consideration the potential burdens and side effects of any treatment that leads to improvement in specific symptoms but that may negatively affect general well being. This paper reviews currently available data on the assessment of quality of life in patients with AF. Furthermore, the definition and usefulness of different clinical patterns and classifications of AF with regard to quality of life are discussed. Finally, tools and definitions for further clinical research are suggested.

Key Words: Atrial fibrillation • Quality of life • Clinical trials • Classification • Treatment outcome

References

  1. Wells JL Jr, Karp RB, Kouchoukos NT, et al. Characterization of atrial fibrillation in man: studies following open heart surgery. Pacing Clin Electrophysiol. 1978;1:426–438[CrossRef][Medline]
  2. Ortiz J, Niwano S, Abe H, et al. Mapping the conversion of atrial flutter to atrial fibrillation and atrial fibrillation to atrial flutter. Insights into mechanisms. Circ Res. 1994;74:882–894[Abstract/Free Full Text]
  3. Israel CW, Ehrlich JR, Gronefeld G. Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: insights. 1994;:
  4. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659–666[Abstract/Free Full Text]
  5. Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982;306:1018–1022[Abstract]
  6. Takahashi N, Seki A, Imataka K, et al. Clinical features of paroxysmal atrial fibrillation. An observation of 94 patients. Jpn Heart J. 1981;22:143–149[Medline]
  7. Levy S, Maarek M, Coumel P, et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. Circulation. 1999;99:3028–3035[Abstract/Free Full Text]
  8. Sopher SM, Camm AJ. Atrial fibrillation: maintenance of sinus rhythm versus rate control. Am J Cardiol. 1996;77:24A–37A[CrossRef][Medline]
  9. Prystowsky EN, Benson DW Jr., Fuster V, et al. Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation. 1996;93:1262–1277[Free Full Text]
  10. Nattel S, Hadjis T, Talajic M. The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations. Drugs. 1994;48:345–371[Web of Science][Medline]
  11. Gallagher MM, Camm AJ. Classification of atrial fibrillation. Pacing Clin Electrophysiol. 1997;20:1603–1605[CrossRef][Medline]
  12. Pritchett EL. The case for just plain ‘atrial fibrillation’. Pacing Clin Electrophysiol. 1998;21:637–640[CrossRef][Medline]
  13. Flaker GC, Fletcher KA, Rothbart RM, et al. Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Am J Cardiol. 1995;76:355–358[CrossRef][Web of Science][Medline]
  14. Levy S, Novella P, Ricard P, et al. Paroxysmal atrial fibrillation: a need for classification. J Cardiovasc Electrophysiol. 1995;6:69–74[Web of Science][Medline]
  15. Curtis AB. How to approach classification of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 1995;6:75–77[Web of Science][Medline]
  16. Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82:2N–9N[CrossRef][Web of Science][Medline]
  17. Dries DL, Exner DV, Gersh BJ, et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1998;32:695–703[Abstract/Free Full Text]
  18. Albers GW, Dalen JE, Laupacis A, et al. Antithrombotic therapy in atrial fibrillation. Chest. 2001;119:194S–206S (1 Suppl)[Free Full Text]
  19. Lip GY, Tean KN, Dunn FG. Treatment of atrial fibrillation in a district general hospital. Br Heart J. 1994;71:92–95[Abstract/Free Full Text]
  20. Bubien RS, Kay GN, Jenkins LS. Test specifications for symptom checklist: frequency and severity. Milwaukee: University of Milwaukee; 1994.
  21. Savelieva I, Paquette M, Dorian P, et al. Quality of life in patients with silent atrial fibrillation. Heart. 2001;85:216–217[Free Full Text]
  22. Kay GN, Ellenbogen KA, Giudici M, et al. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators. J Interv Card Electrophysiol. 1998;2:121–135[CrossRef][Web of Science][Medline]
  23. Bubien RS, Knotts-Dolson SM, Plumb VJ, et al. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation. 1996;94:1585–1591[Abstract/Free Full Text]
  24. Dorian P, Jung W, Newman D, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol. 2000;36:1303–1309[Abstract/Free Full Text]
  25. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet. 2000;356:1789–1794[CrossRef][Web of Science][Medline]
  26. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996;334:835–840[Free Full Text]
  27. Hamer ME, Blumenthal JA, McCarthy EA, et al. Quality-of-life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia. Am J Cardiol. 1994;74:826–829[CrossRef][Web of Science][Medline]
  28. Kay GN, Bubien RS, Epstein AE, et al. Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation. Am J Cardiol. 1988;62:741–744[CrossRef][Web of Science][Medline]
  29. Brignole M, Gianfranchi L, Menozzi C, et al. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. Circulation. 1997;96:2617–2624[Abstract/Free Full Text]
  30. Brignole M, Menozzi C, Gianfranchi L, et al. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. Circulation. 1998;98:953–960[Abstract/Free Full Text]
  31. Paquette M, Roy D, Talajic M, et al. Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. Am J Cardiol. 2000;86:764–768[CrossRef][Web of Science][Medline]
  32. Lönnerholm S, Blomstrom P, Nilsson L, et al. Effects of the maze operation on health-related quality of life in patients with atrial fibrillation. Circulation. 2000;101:2607–2611[Abstract/Free Full Text]
  33. van den Berg MP, Hassink RJ, Tuinenburg AE, et al. Quality of life in patients with paroxysmal atrial fibrillation and its predictors: importance of the autonomic nervous system. Eur Heart J. 2001;22:247–253[Abstract/Free Full Text]
  34. Jung W, Herwig S, Newman D, et al. Impact of atrial fibrillation on quality of life: a prospective multicenter study. [abstract]J Am Coll Cardiol. 1999;33(Supp A):104A
  35. Levy T, Walker S, Mason M, et al. Importance of rate control or rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left ventricular function: a randomised controlled study. Heart. 2001;85:171–178[Abstract/Free Full Text]
  36. Fitzpatrick AP, Kourouyan HD, Siu A, et al. Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation. Am Heart J. 1996;131:499–507[CrossRef][Web of Science][Medline]
  37. Lee SH, Chen SA, Tai CT, et al. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation. J Am Coll Cardiol. 1998;31:637–644[Abstract/Free Full Text]
  38. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA. 1989;262:907–913[Abstract/Free Full Text]
  39. McHorney CA, Ware JE Jr., Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247–263[Web of Science][Medline]
  40. Ware JE. The SF-36 Health Survey Manual and Interpretation Guide. Boston, Massachusetts: The Health Institute, New England Medical Center; 1993.
  41. Wood MA, Brown-Mahoney C, Kay GN, et al. Clinical out-comes after ablation and pacing therapy for atrial fibrillation: a meta-analysis. Circulation. 2000;101:1138–1144[Abstract/Free Full Text]
  42. Jung W, Luderitz B. Quality of life in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 1998;9:S177–S186 (8 Suppl)[Web of Science][Medline]
  43. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825–1833[Abstract/Free Full Text]
  44. Jenkins LS, Schron E, Brodsky M, et al. Quality of life in patients with atrial fibrillation: Baseline data from AFFIRM. [abstract]Circulation. 2001;102:1–2488 (Suppl)
  45. Smith HJ, Taylor R, Mitchell A. A comparison of four quality of life instruments in cardiac patients: SF-36, QLI, QLMI, and SEIQoL. Heart. 2000;84:390–394[Abstract/Free Full Text]
  46. Ganiats TG, Browner DK, Dittrich HC. Comparison of Quality of Well-Being scale and NYHA functional status classification in patients with atrial fibrillation. New York Heart Association. Am Heart J. 1998;135:819–824[CrossRef][Web of Science][Medline]
  47. Ware JE Jr, Kosinski M, Gandek B, et al. The factor structure of the SF-63 Health Survey in 10 countries; results from the IQQLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:1159–1165[CrossRef][Web of Science][Medline]
  48. Wagner AK, Gandek B, Aaronson NK, et al. Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:925–932[CrossRef][Web of Science][Medline]
  49. Bradley C. Importance of differentiating health status from quality of life. Lancet. 2001;357:7–8[CrossRef][Web of Science][Medline]
  50. Connolly SJ. Appropriate outcome measures in trials evaluating treatment of atrial fibrillation. Am Heart J. 2000;139:752–760[Web of Science][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
R. H. Falk
Atrial Fibrillation or Sinus Rhythm?: Controversy and Contradiction in Quality of Life Outcomes
J. Am. Coll. Cardiol., August 15, 2006; 48(4): 731 - 733.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Grönefeld, G.C.
Right arrow Articles by Hohnloser, S.H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Grönefeld, G.C.
Right arrow Articles by Hohnloser, S.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?